Publications by authors named "David Newitt"

Claim this Profile
B
Breast Multiparametric MRI for Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: The BMMR2 Challenge.
Wen Li, Savannah C Partridge, David C Newitt, Jon Steingrimsson, Helga S Marques

Radiol Imaging Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment.
Natsuko Onishi, Teffany Joy Bareng, Jessica Gibbs, Wen Li, Elissa R Price, David C Newitt

Radiol Imaging Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after breast neoadjuvant chemotherapy.
Rhea Chitalia, Marios Miliotis, Nariman Jahani, Spyros Tastsoglou, Elizabeth S McDonald, David Newitt

Commun Med (Lond)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy.
Wen Li, Nu N Le, Natsuko Onishi, David C Newitt, Lisa J Wilmes

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert tumor annotations and radiomics for locally advanced breast cancer in DCE-MRI for ACRIN 6657/I-SPY1.
Rhea Chitalia, Sarthak Pati, Megh Bhalerao, Siddhesh Pravin Thakur, Nariman Jahani, David C Newitt

Sci Data· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of deformable registration methods for prediction of recurrence free survival response to neoadjuvant chemotherapy in breast cancer: Results from the ISPY 1/ACRIN 6657 trial.
Snekha Thakran, Eric Cohen, Nariman Jahani, Susan P Weinstein, Lauren Pantalone, David Newitt

Transl Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Inter-Reader Variability on Diffusion-Weighted MRI Apparent Diffusion Coefficient Measurements and Prediction of Pathologic Complete Response for Breast Cancer.
Nu N Le, Wen Li, Natsuko Onishi, David C Newitt, Jessica E Gibbs

Tomography· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Alternate -Value Combinations and Metrics on the Predictive Performance and Repeatability of Diffusion-Weighted MRI in Breast Cancer Treatment: Results from the ECOG-ACRIN A6698 Trial.
Savannah C Partridge, Jon Steingrimsson, David C Newitt, Jessica E Gibbs, Helga S Marques

Tomography· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response.
Alex Anh-Tu Nguyen, Natsuko Onishi, Julia Carmona-Bozo, Wen Li, John Kornak, David C Newitt

Tomography· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Stability of Gradient Characteristics Warrants Model-Based Correction of Diffusion Weighting Bias.
Yuxi Pang, Dariya I Malyarenko, Lisa J Wilmes, Ajit Devaraj, Ek T Tan, David C Newitt

Tomography· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.
Natsuko Onishi, Wen Li, David C Newitt, Roy J Harnish, Fredrik Strand

Radiology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk.
Mark Jesus M Magbanua, Wen Li, Denise M Wolf, Christina Yau, Gillian L Hirst, David C Newitt

NPJ Breast Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Denoising and Multiple Tissue Compartment Visualization of Multi-b-Valued Breast Diffusion MRI.
Ek T Tan, Lisa J Wilmes, Bonnie N Joe, Natsuko Onishi, Vignesh A Arasu, David C Newitt

J Magn Reson Imaging· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL.
Wen Li, David C Newitt, Jessica Gibbs, Lisa J Wilmes, Ella F Jones

NPJ Breast Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Breast MRI Background Parenchymal Enhancement for Neoadjuvant Treatment Response among HER2- Patients.
Vignesh A Arasu, Paul Kim, Wen Li, Fredrik Strand, Cody McHargue, David C Newitt

J Breast Imaging· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial.
Natsuko Onishi, Wen Li, Jessica Gibbs, Lisa J Wilmes, Alex Nguyen, David C Newitt

Tomography· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Correction of ADC for Gradient Nonlinearity Errors in Multicenter Breast DWI Trials: ACRIN6698 Multiplatform Feasibility Study.
Dariya I Malyarenko, David C Newitt, Ghoncheh Amouzandeh, Lisa J Wilmes, Ek T Tan

Tomography· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy.
Alex Anh-Tu Nguyen, Vignesh A Arasu, Fredrik Strand, Wen Li, Natsuko Onishi, David C Newitt

Tomography· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeatability and Reproducibility of ADC Histogram Metrics from the ACRIN 6698 Breast Cancer Therapy Response Trial.
David C Newitt, Ghoncheh Amouzandeh, Savannah C Partridge, Helga S Marques, Benjamin A Herman

Tomography· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer.
Wen Li, David C Newitt, Bo La Yun, Ella F Jones, Vignesh Arasu

Tomography· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL.
Wen Li, David C Newitt, Lisa J Wilmes, Ella F Jones, Vignesh Arasu

J Magn Reson Imaging· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Treatment Response to Neoadjuvant Chemotherapy for Breast Cancer via Early Changes in Tumor Heterogeneity Captured by DCE-MRI Registration.
Nariman Jahani, Eric Cohen, Meng-Kang Hsieh, Susan P Weinstein, Lauren Pantalone, David Newitt

Sci Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.
David C Newitt, Zheng Zhang, Jessica E Gibbs, Savannah C Partridge, Thomas L Chenevert

J Magn Reson Imaging· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion-weighted MRI in Multicenter Trials of Breast Cancer.
Savannah C Partridge, David C Newitt, Thomas L Chenevert, Mark A Rosen, Nola M Hylton

Radiology· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.
Savannah C Partridge, Zheng Zhang, David C Newitt, Jessica E Gibbs, Thomas L Chenevert

Radiology· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis